Israeli Health Ministry Certifies Cannabis Vaporizer as Medical Device
Kanabo’s VapePod allows users to inhale precise doses of marijuana from extracts
The country’s health ministry in recent weeks certified a vaporizer device developed by Israel-based Kanabo Research Ltd. after a review of its specifications and performance.
Kanabo’s VapePod allows users to consume marijuana extracts in precise doses, which is why ministry officials gave it the green light, Avihu Tamir, the startup’s co-founder and chief executive, said in an interview.
Founded in 2017 and based in Tel Aviv, Kanabo plans to bring the product to market in the coming months, Mr. Tamir added. Sales in Europe should begin next quarter, followed by distribution in Israel in June, if additional bureaucratic hurdles are resolved.
A medical device certification will allow Kanabo to sell its products through pharmacies and healthcare providers, Mr. Avihu said.
“Until medical validation happens, the stigma around medical marijuana is not going to end,” he said.
Kanabo also announced the beginning of trials to test marijuana extract formulas for their efficacy in treating sleep disorders.
In the future, the startup plans to introduce a device that monitors patient usage, gathering data to improve treatment and to apply in research.
Israel is home to about 70 cannabis-related startups, which employ more than 900 people and have raised a total of $76 million, according to a recent report by IVC Research Center Ltd., a Tel Aviv-based research center.
The country has become a major destination for researchers who want to conduct medical studies with cannabis due to welcoming regulations by the health ministry.